Pain Research and Management

Pain Research and Management / 2002 / Article

Editorial | Open Access

Volume 7 |Article ID 124295 | https://doi.org/10.1155/2002/124295

Harold Merskey, Ellen N Thompson, "Nerve Blocks and Cognitive Therapy: A Beneficial Failure", Pain Research and Management, vol. 7, Article ID 124295, 4 pages, 2002. https://doi.org/10.1155/2002/124295

Nerve Blocks and Cognitive Therapy: A Beneficial Failure

Abstract

The trial by Gale et al (pages 185-189) is a valuable example of a negative result - the sort of finding that is published less often than a positive one. But, we can learn from the failure, both in understanding correct treatment and in planning future trials. Patients were recruited in a clinic where repeated treatment by nerve blocks is used as a palliative measure for chronic pain of all types. They were then offered the choice of entering a group with cognitive behavioural therapy or continuing with nerve blocks. For ethical reasons, patients could freely leave either branch of the trial without prejudice. At the onset, one of 34 patients in the nerve-block group left, while 12 departed from the cognitive therapy group. All 33 patients remaining in the nerve block group completed the eight-week trial, while only four of 34 patients completed it in the cognitive therapy group.

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views35
Downloads195
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.